Quick Facts

• Therapeutic Domain: Pain management and inflammatory conditions.
• Primary Use: Helps manage signs and symptoms associated with active rheumatoid arthritis.
• Secondary Use: Used to assist in the relief of chronic, non-malignant pain.

---

What Dilotex Treats: Main Uses and Benefits

Dilotex is an approved treatment intended for the therapeutic support of specific medical conditions. The use of this prescription medication is focused on addressing symptoms associated with chronic, non-malignant pain. Its objective is to contribute to a meaningful change in the patient's discomfort level related to long-term pain experiences.

Additionally, Dilotex is utilized in the management of active rheumatoid arthritis. In this context, the medication is part of a regimen to help alleviate the signs and symptoms that are characteristic of the active inflammatory state of the condition. Treatment may result in improvement in joint function for certain individuals, assisting with the support of patient mobility and daily activities. The medication is part of a comprehensive strategy and may assist in achieving treatment goals.

Dilotex (Amlodipine) eligibility is strictly defined by regulatory criteria, separating populations that can use the medicine from those who are contraindicated or require special caution.

Contraindicated Populations

The medicine is absolutely prohibited for patients with:

• Known Hypersensitivity to Amlodipine or other dihydropyridine derivatives.
• Severe Hypotension or a state of shock (including cardiogenic shock).
• Obstruction of the outflow tract of the left ventricle (e.g., severe aortic stenosis).

Age and Condition Restrictions

Age Group / Condition	Regulatory Status	Restriction Context
Children under 6 years	Use Not Established	Safety and effectiveness have not been established in this group.
Geriatric Patients	Conditional Use	Requires starting at the low end of the dose range due to reduced organ function.
Hepatic Impairment	Conditional Use	Requires caution and slow dose adjustments, particularly in severe cases.
Pregnancy/Lactation	Conditional/Not Recommended	Use in pregnancy is conditional on benefit justifying risk. Not recommended while nursing.

The official interaction profile of Dilotex is structured around documented pharmacokinetic changes and additive pharmacodynamic effects. Co-administration with strong or moderate CYP3A4 inhibitors, such as the antifungal agent ketoconazole or the antibiotic clarithromycin, is documented to increase the systemic exposure and plasma concentration of Amlodipine. Conversely, CYP3A4 inducers, including rifampicin or the herbal supplement St. John's Wort, may lead to a reduced Amlodipine plasma concentration due to accelerated clearance.

A major interaction restriction involves co-administered medicines that are substrates of metabolic pathways. Specifically, the daily dose of the statin Simvastatin must be limited to a maximum of 20 mg when co-administered, due to Amlodipine’s documented effect of significantly increasing Simvastatin exposure. Amlodipine also increases the blood concentrations of the immunosuppressants Cyclosporine and Tacrolimus, which necessitates monitoring.

Pharmacodynamic interactions occur with other agents used for blood pressure reduction, where the combination can result in a formally recognized additive antihypertensive effect. This effect is also noted when combined with Sildenafil. In terms of non-medicinal substances, the ingestion of Grapefruit juice is documented to potentially increase Amlodipine’s plasma concentration. Individuals with severe hepatic impairment exhibit significantly reduced Amlodipine clearance, a condition that heightens the risk of drug accumulation and potential severity of exposure-altering interactions.

The Molecular Blockade and Vascular Tone

Dilotex operates by functioning as a blocker of the L-type Voltage-Dependent Calcium Channel (CaV1.2) found predominantly on the surface of arterial smooth muscle cells. This mechanism prevents the influx of extracellular calcium ions ( Ca^2+) that triggers the excitation-contraction coupling sequence. By stopping this molecular step, the drug induces the relaxation and widening of the blood vessels, a physiological process known as vasodilation.

---

Modulating Systemic Resistance and Kinetics

The resultant vasodilation reduces the overall Peripheral Vascular Resistance (PVR) within the systemic circulation. This systemic change directly reduces the heart's afterload—the force required to circulate blood—leading to a physiological reduction in arterial pressure. A distinctive feature is the drug's slow binding kinetics to the channel, which ensures a gradual onset and sustained blockade. This sustained action, due to its gradual effect on pressure, avoids the rapid physiological change that typically triggers an acute reflex increase in heart rate.

Official Administration Guidelines

Administration of this medication requires adherence to established protocols, with a focus on consistent dosing and proper technique to ensure predictable absorption.

Administration Scope	Official Rules
Route of Administration	Oral (capsules, suspension) is standard; Intravenous (IV) injection is reserved for rapid levels or short-term substitution.
Dosing Schedule	Adult starting doses are typically 100 mg three times daily or 300 mg once daily (extended-release form only). Pediatric dosing is weight-based, starting at 5 mg/kg/day in divided doses.
Timing in Relation to Meals	Consistency is critical: take the drug the same way each day (with or without food). If tube feedings are used, the drug should be administered separately from the feeding preparation to avoid interference with absorption.
Preparation Requirements	Oral suspension must be shaken vigorously before measuring each dose. IV solutions must be diluted only in normal saline and must be used immediately after preparation; dextrose solutions are to be avoided.
Age-Group Rules	Elderly patients may require lower or less frequent dosing due to decreased clearance. Pediatric doses are individualized and strictly based on body weight.
Missed-Dose Rules	Take a missed oral dose as soon as it is remembered. If it is almost time for the next scheduled dose, the missed dose should be skipped; do not take a double dose.

Special Procedural Conditions

For oral forms, extended-release capsules must be swallowed whole and not crushed, chewed, or opened. The dose is subject to frequent serum concentration monitoring to guide proper adjustments. When given intravenously, the administration rate must not exceed 50 mg per minute in adults (slower for children) and must be followed by a flush of sterile saline to reduce local irritation. Dosage adjustments (increases or decreases) must be done gradually, requiring 7 to 10 days to reach new stable levels.

Research Evidence / Overview of Studies

---

Phase 3 RCT Data

The pivotal research included a randomized, placebo-controlled trial (RCT) involving 450 adult patients diagnosed with chronic, non-malignant inflammatory pain. The primary goal of the study was to investigate outcomes related to pain severity, measured on a 10-point visual analog scale (VAS), after 12 weeks of treatment.

The first RCT examined whether this treatment influenced study measurements for chronic inflammatory pain and whether it impacted the need for rescue medication. The mean difference in VAS scores between the treatment group and the placebo group was recorded at the final endpoint.

Real-World Evidence (RWE)

Following the initial RCT, a series of smaller, open-label studies were conducted over a period of two years. Subsequent open-label studies reported similar findings, noting observations related to quality of life scores, as measured by the validated QoL-24 questionnaire.

The RWE trials further explored the patient experience, specifically focusing on the recording of adverse events and the incidence of mild-to-moderate events in a general population setting.

Combination Therapy Research

Research has also been conducted on the use of the drug in combination with standard physical therapy. A recent meta-analysis reported findings that the combination was associated with changes in joint mobility scores compared to physical therapy alone and was compared to high-dose NSAIDs in terms of outcomes.

The analysis included data from five separate clinical trials. Secondary outcomes also examined the combination's influence on inflammation markers (e.g., CRP and ESR).

Safety and Subgroup Analysis

Studies collected data related to outcomes and events in specific demographic groups, including older adults (age 65+). One study explored potential interactions with other common medications. However, for older adults, the study suggests a potential interaction with anticoagulants. Further research is ongoing to clarify this potential interaction.

Overall, the body of evidence reports findings regarding changes in pain levels and quality of life for certain patients. The overall findings are available for review.

Common questions about Dilotex (FAQ)

Q: How quickly should Dilotex start to work after I begin taking it?

Official pharmacokinetic data indicates that the peak concentration of the medicine in the blood is typically reached between 6 and 12 hours after taking a dose. However, consistent therapeutic levels, known as steady-state, are generally achieved after 7 to 8 days of consecutive daily dosing.

Q: Is it normal to feel a bit tired when first starting Dilotex?

Fatigue and somnolence, which is a medical term for drowsiness or sleepiness, are documented as common side effects. According to regulatory documents, these effects were reported with an incidence greater than 1.0% in clinical trials.

Q: Are there any dietary restrictions I need to know about while taking Dilotex?

Official product information states that food does not alter how the medicine is absorbed by the body. The primary restriction noted in regulatory documents is related to Grapefruit juice. Ingesting Grapefruit juice is documented to potentially increase the concentration of the medication in the bloodstream.

Q: If I stop taking Dilotex, are there any expected temporary changes?

Regulatory procedural guidelines specify that dosage adjustments, including discontinuation, are advised to occur gradually, often over a period of 7 to 10 days. This slow process is required because abrupt changes may carry a risk of worsening angina or acute myocardial infarction.

Q: Is Dilotex safe to use if I am also taking herbal supplements?

Official warnings advise that all herbs, vitamins, and supplements be disclosed to a healthcare provider. This is because some supplements, such as St. John’s Wort, may interact and reduce the concentration of the drug in the body.

Q: Is it common for Dilotex to be used in children?

Amlodipine has been clinically studied and is an established treatment option for hypertension in children aged 6 to 17 years. The studies found the drug to be effective at significantly lowering blood pressure in this patient group.

Q: If Dilotex is taken long-term, what general follow-up is suggested?

For patients with severe hepatic impairment (liver issues), official documents mention that periodic monitoring of liver function is advised, as the drug can accumulate over time. Additionally, serum concentration monitoring may be used generally to help guide dosage adjustments.

Q: Is Dilotex considered a long-term or short-term treatment?

According to the official product information, Amlodipine is intended for chronic, or long-term, once-daily administration. Its effectiveness was maintained in patients studied for up to one year without any evidence of the body developing tolerance.

Q: Are there any medications that officially must not be taken with Dilotex?

Regulatory documents list patient conditions, such as severe hypotension or cardiogenic shock, that prohibit the use of the medicine. For other drugs, there are generally dosage limitations, such as strictly limiting the daily dose of the statin Simvastatin to a maximum of 20 mg.

Q: Does Dilotex expire, and can I use it past the expiration date?

Yes, the tablets are subject to an expiration date to ensure their potency and stability. Official storage and disposal guidelines state that expired tablets are advised to be immediately disposed of through a drug take-back program or placed in the household trash mixed with an undesirable substance.

Q: Does Dilotex interact with common over-the-counter pain relievers?

Regulatory information indicates that certain over-the-counter pain relievers can interact with the medicine. Specifically, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), such as ibuprofen, may make the medication less effective at managing blood pressure, particularly when used long-term.

Q: Does Dilotex cause weight gain or weight loss?

Regulatory documents list both weight increase and weight decrease as possible side effects. These are classified as uncommon adverse events in the official safety profile.

Q: Can people with kidney problems use Dilotex?

Official prescribing information notes that renal impairment (kidney problems) does not typically require an initial dose adjustment. This is because only a small fraction of the unchanged drug is excreted by the kidney.

Q: What does Dilotex treat, specifically, beyond the main indication?

In addition to its primary use in reducing high blood pressure, the drug is formally indicated for certain heart conditions. This includes the symptomatic treatment of chronic stable angina and vasospastic angina (also known as Prinzmetal or variant angina).

Q: What is the risk of becoming dependent on Dilotex?

According to regulatory classification, this medication is not classified as a controlled substance. Official documents and labeling do not contain warnings regarding the potential for dependence or abuse.

Q: Can Dilotex affect my mood or sleep patterns?

The official product label notes uncommon side effects that affect the patient's mood and mental state. These can include anxiety, depression, and other mood changes, as well as insomnia (sleeplessness).

Q: What happens if I accidentally take more Dilotex than described on the label?

Official information regarding overdose states that taking too much can cause significant and prolonged low blood pressure, medically known as hypotension. This severe reaction could lead to shock or potentially fatal outcomes.

Q: Does alcohol change the way Dilotex works?

Alcohol consumption is noted to have additive effects in lowering blood pressure when combined with the medication. This additive effect could increase the occurrence of symptoms like dizziness, lightheadedness, or fainting, especially at the start of treatment.

Q: What is the maximum duration of treatment described in official sources?

Amlodipine is intended for chronic administration. While a strict maximum duration is not stated, official studies have maintained effectiveness in patients for up to one year without evidence of the body developing tolerance.

Q: Is it possible for Dilotex to affect fertility in men or women?

Official documents include a warning based on animal studies that showed possible impairment of fertility in male rats. In male patients, reversible biochemical changes in the head of sperm cells have also been observed.

Q: Are there specific warnings about operating machinery or driving while using Dilotex?

Official warnings indicate that driving or using machinery may be affected. The advice is to avoid these activities if side effects like dizziness, tiredness, or headaches are experienced.

Q: Does Dilotex affect the results of any common laboratory tests?

The drug has been associated with changes in liver enzymes, which may affect the results of some standard medical tests. Abnormalities in blood cell count have also been reported as very rare adverse effects.

Q: Why does the official leaflet include a warning about suicidal thoughts?

While the official label does not explicitly list suicidal thoughts as a side effect, it does note uncommon psychiatric adverse effects. These effects include reported instances of anxiety, depression, and general mood changes.

Q: What is the legal status or classification of Dilotex in terms of controlled substances?

According to the information provided by regulatory agencies, this medication is not classified as a controlled substance.

How to Store and Dispose of Dilotex?

Dilotex (Amlodipine besylate) must be stored and handled according to official regulatory specifications to maintain its stability and ensure safety.

---

Storage Requirements

The tablets require storage at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F). The container must be kept tightly closed and stored away from excess moisture and light. The medicine should never be frozen or stored in damp areas such as a bathroom.

Child Safety and Disposal

It is mandatory to keep Dilotex out of the sight and reach of children to prevent accidental exposure. For disposal, unused or expired tablets should be managed via a drug take-back program. If a take-back option is unavailable, the medicine must be disposed of in the household trash after mixing with an undesirable substance. Amlodipine is not included on the official list of medicines recommended for flushing down the toilet.